Navigation Links
Survivors of 1918 Flu Pandemic Immune 90 Years Later
Date:8/17/2008

Finding could lead to new strategies for fighting future pandemics, researchers say

SUNDAY, Aug. 17 (HealthDay News) -- People who lived through the 1918 flu pandemic that killed 50 million worldwide are still producing antibodies to the virus 90 years later, researchers report.

"Most people have a notion that elderly people have very weak immunity or they have lost immunity," said lead researcher Dr. James E. Crowe Jr., a professor of pediatrics, microbiology and immunology at Vanderbilt University.

"This study shows that extremely elderly people have retained memory of being infected with the 1918 flu, even 90 years later," Crowe said.

This is the first evidence that shows that people developed significant immunity to the 1918 flu virus, Crowe said. "It's important to know that you can develop immunity to such a pandemic virus. That has implications for new pandemic viruses," he said.

The report is published in the Aug. 17 issue of Nature.

For the study, Crowe's team studied antibodies in the blood of 32 people in their 90s and 100s, born during or before 1915. They found that all 32 people had antibodies to the 1918 strain of flu virus. In fact, several of these people were still producing the antibodies to the virus.

In experiments with mice, the researchers found that these antibodies continue to protect the mice from infection with the 1918 flu strain.

The study also shows that people have a "surprising ability" to maintain immunity to things they saw a long time ago, Crowe said.

Whether this long-term immunity is peculiar to the 1918 flu virus isn't known, Crowe said. He believes more work needs to be done understand the full extent of this immune response. "The elderly might be a very good donor source for finding antibodies against viruses," he said.

"This study shows that humans can develop very potent immune responses against dangerous influenza that cause pandemics," Crowe said. "It gives us hope that we can develop vaccines and antibody treatments for any other pandemic viruses that come along," he said.

Dr. Marc Siegel, an associate professor of medicine at New York University School of Medicine in New York City, thinks that people who developed this strong immune response may have been infected with a less deadly strain of flu before 1918.

"The implication of this study is the 1918 virus was so powerful that the immunity you had to have in order to survive was so prominent that it lasted for the rest of your life," Siegel said.

However, Siegel noted that some people may have had experience with a similar less deadly flu virus that prepared their immune system to handle the 1918 strain.

"So, those in certain age groups who had seen a related virus had the strongest responses," Siegel said. "Either they died, or they developed a profound immune response," he said.

Siegel expects if there is another flu pandemic, some people will develop a lifelong immunity as they did in 1918.

More information

For more on avian flu, visit the U.S. Centers for Disease Control and Prevention.



SOURCES: James E. Crowe Jr., M.D., professor, pediatrics, microbiology and immunology, Vanderbilt University, Nashville, Tenn.; Marc Siegel, M.D., associate professor, medicine, New York University School of Medicine, New York City, author, Bird Flu: Everything You Need to Know About the Next Pandemic; Aug. 17, 2008, Nature


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. One Year Later: Red Cross Helping Peru Earthquake Survivors Rebuild
2. One-Fifth of British Childhood Cancer Survivors Smoke
3. American Cancer Society study finds high use of complementary methods among cancer survivors
4. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
5. 1/5 of British adult survivors of childhood cancer smoke despite hazards
6. Video: A Toast to the Cure Set for October 30 Breast Cancer Survivors Raise Your Glasses
7. Angina Strikes 1 in 5 Heart Attack Survivors
8. ASTRO, The Wellness Community - Greater Boston Join to Promote Cancer Survivorship
9. Experts highlight gaps in knowledge on caring for survivors of teenage and young adult cancers
10. Poor sleep a problem in long-term breast cancer survivors
11. Nonprofit Organization Dedicated to Helping Young Adult Cancer Survivors Raises $4500 for Leanna Elizalde
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Survivors of 1918 Flu Pandemic Immune 90 Years Later
(Date:12/6/2016)... ... December 06, 2016 , ... ... until January 15, 2017 to apply for a 2016/2017 California Casualty Thomas R. ... . Qualifying schools can receive up to $3,000. , The grant ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... in research and development, largely due to its potential for revolutionizing human disease ... (hMSCs) and human induced pluripotent stem cells (hiPSCs). , Both platforms have ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has ... the world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every ...
(Date:12/6/2016)... ... 2016 , ... TopConsumerReviews.com recently gave a best-in-class 5 star rating to SpinLife, ... freedom to people who need help getting around. For some, advancing age has led ... of rehabilitation after an illness or accident. There is a wide variety of scooters, ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)...  Cornerstone Pharmaceuticals, Inc., a privately held, clinical-stage, ... Phase I trials evaluating its lead compound, CPI-613, ... of the American Society of Hematology (ASH) in ... two datasets show encouraging efficacy and safety results ... T-cell non-Hodgkin,s lymphoma (T-cell NHL), respectively, supporting the ...
(Date:12/5/2016)... , Dec. 5, 2016  Pennsylvania Physician General Dr. ... Alcohol Programs Gary Tennis today filled prescriptions ... Minnich,s Pharmacy in York to ... by Dr. Levine as a prescription to acquire naloxone ... "It,s important to remember that any Pennsylvanian can walk ...
Breaking Medicine Technology: